Sofosbuvir. See Important Safety Information including Important Warning. Sofosbuvir is a prodrug and after ingestion it is rapidly converted to GS-331007 the predominant circulating drug that accounts for.
Sofosbuvir and velpatasvir is a combination antiviral medicine used to treat chronic hepatitis C in adults and children at least 6 years old or weighing at least 37 pounds 17 kilograms. It works by decreasing the amount of hepatitis C virus HCV in the body. EPCLUSA sofosbuvir 400 mgvelpatasvir 100 mg Patient Site Discover EPCLUSA a prescription medicine used to treat chronic hepatitis c.
Sofosbuvir tradename Sovaldi is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C an infectious liver disease caused by infection with Hepatitis C Virus HCV.
In patients without alternative viable treatment options cardiac monitoring is recommended. Sofosbuvir may not prevent the spread of hepatitis C to other people. Sofosbuvir is a prodrug and after ingestion it is rapidly converted to GS-331007 the predominant circulating drug that accounts for. Food and Drug Administration FDA for the treatment of chronic hepatitis C virus infection HCV in adults and children 3 years of age and older who meet specific requirements as determined by a health care provider.